HILYSENS II

Demonstration Activities for the clinical validation of the prototype HILYSENS Lab-on-a-Chip

 Coordinatore "STAB VIDA, INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA." 

 Organization address address: RUA DOS INVENTORES SN EDIFICIO MADAN SETUBAL CONCELHO ALMADA FREGUESIA CAPARICA E TRAFARIA
city: OEIRAS
postcode: 2825 182

contact info
Titolo: Ms.
Nome: Daniela
Cognome: Leao
Email: send email
Telefono: +351 210438606

 Nazionalità Coordinatore Portugal [PT]
 Totale costo 2˙180˙800 €
 EC contributo 1˙264˙000 €
 Programma FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs
 Code Call FP7-SME-2013
 Funding Scheme CP
 Anno di inizio 2014
 Periodo (anno-mese-giorno) 2014-04-01   -   2016-03-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    "STAB VIDA, INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA."

 Organization address address: RUA DOS INVENTORES SN EDIFICIO MADAN SETUBAL CONCELHO ALMADA FREGUESIA CAPARICA E TRAFARIA
city: OEIRAS
postcode: 2825 182

contact info
Titolo: Ms.
Nome: Daniela
Cognome: Leao
Email: send email
Telefono: +351 210438606

PT (OEIRAS) coordinator 431˙400.00
2    MICRO BIO DEVICES S.R.L

 Organization address address: VIA ROMA 72
city: FILIGNANO ISERNIA
postcode: 86074

contact info
Titolo: Mr.
Nome: Giovanni Ugo
Cognome: Altieri
Email: send email
Telefono: +39 0865 926013

IT (FILIGNANO ISERNIA) participant 298˙200.00
3    microLIQUID sl

 Organization address address: Av. Uribarri 19-1
city: Arrasate-Mondragon
postcode: 20500

contact info
Titolo: Dr.
Nome: Borja
Cognome: Barredo
Email: send email
Telefono: +34 943712072

ES (Arrasate-Mondragon) participant 296˙600.00
4    B-C-A BORRELIOSE CENTRUM AUGSBURG BETRIEBS GMBH & CO KG

 Organization address address: MORELLSTRASSE 33
city: AUGSBURG
postcode: 86199

contact info
Titolo: Dr.
Nome: Armin
Cognome: Schwarzbach
Email: send email
Telefono: 498215000000

DE (AUGSBURG) participant 133˙200.00
5    GOETEBORGS UNIVERSITET

 Organization address address: VASAPARKEN
city: GOETEBORG
postcode: 405 30

contact info
Titolo: Dr.
Nome: Ellen
Cognome: Rydberg
Email: send email
Telefono: 46317866470

SE (GOETEBORG) participant 104˙600.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

portugal    bio    prototype    smes    reader    borrelia    demonstration    species    lyme    chronic    sensitive    disease    followed    chip    late    hilysens    diagnostic   

 Obiettivo del progetto (Objective)

'HILYSENS II is based on the 2-year HILYSENS research and development project (started November 2010) funded by the ‘Research for the Benefit of SMEs’ program of the European Commission's Seventh Framework Programme (FP7). HILYSENS II proposes Demonstration Activities for the prototype HILYSENS Lab-on-a-Chip developed during the successful research and development project, which was designed as a specific and sensitive diagnostic system for acute, chronic and autoimmunity-associated Lyme disease. The developed prototype comprises a Bio-Chip, which enables specific and sensitive detection of the human serological responses to Borrelia species in patients with Lyme disease, and a portable Reader with user-friendly software, which together enable precise, accurate and reproducible testing of serum samples. Lyme disease is the most common tick-borne infection in Europe, with around 85,000 new cases per year. Current laboratory diagnostic methods for Borrelia species lack the necessary sensitivity and specificity to detect early cases, as well as late manifestations of the disease, such as chronic or autoimmune-related infections. As a consequence, many cases are undiagnosed or misdiagnosed. Late, delayed, or inadequate treatment can lead to serious problems, such as neuroborreliosis or arthritis, which can be disabling and difficult to treat. The HILYSENS II Demonstration Activity, which will involve SMEs from Portugal, Italy, and Spain, will include verification of the Bio-Chip and Reader components, followed by scaling-up of the production of the complete system. This will be followed by clinical validation at partner Borrelia testing centers in Germany and Sweden, and confirmatory testing in Portugal. By the end of the 24-month Demonstration Activity it is expected that the HILYSENS diagnostic system will be submitted for approval by regulatory authorities in Europe and the US and will enter these markets shortly thereafter.'

Altri progetti dello stesso programma (FP7-SME)

EMFWELD (2012)

"Analysis of workers exposure to electromagnetic fields (EMF) from welding and NDT processes, guidelines for risk assessment and development of risk assessment web based application"

Read More  

PROSYMA (2014)

Process-Optimized System Functionality of Mobile Work Machines

Read More  

HILYSENS (2010)

Highly sensitive and specific low-cost lab-on-a-chip system for Lyme disease diagnosis

Read More